Recently a team of researchers at the Department of Biotechnology’s National Centre for Cell Science (DBT-NCCS) in Pune has been exploring ways to tackle miltefosine (a drug used to treat Leishmaniasis/Kala-azar) resistance. Visceral leishmaniasis, which is commonly known as Kala-azar in India, is fatal in over 95% of the cases if left untreated.
Mechanism of Resistance for Kala-azar
Your email address will not be published. Required fields are marked *
© Powered By Current Hunt, Designed & Developed By Quizsolver.com
This function has been disabled for Current Hunt.